Veracyte, Inc. (VCYT) Stock Performance and Recent Insider Transaction
- Price movement (24‑hour period ending 09:17 PM Central Europe, Thursday 22 Oct 2026): Veracyte shares rose 3.19 %.
- Current trading price: Approximately USD 45.95.
- Shares outstanding: 80.4 million.
- Market capitalization: USD 3.6 billion.
- Volume (last 24 hours): USD 37.5 million.
- Month‑to‑date change: Shares are up 6.6 % since the end of September 2026.
- Technical indicators:
- 200‑day simple moving average: USD 42.62.
- 52‑week high: USD 60.91 (30 Jun 2026).
- 52‑week low: USD 29.46 (27 Mar 2026).
Recent Insider Transaction
On 20 Oct 2026, Veracyte filed a Form 4 reporting a Rule 10b‑5‑1 plan purchase by director Bhanji Muna. The transaction involved 1,864 shares, increasing the director’s holdings to approximately 40,854 shares. The purchase price reflected the company’s market value at the time. No other executive or officer transactions were disclosed in this filing.
Related Stock Performance (Last 24 Hours)
| Ticker | Change | Price | Market Cap (USD bn) | P/E Ratio | Key Note |
|---|---|---|---|---|---|
| GFF | –0.38 % | 95.97 | 4.3 | 19.73 | Mixed quarterly performance; focus on capital adequacy. |
| CVSA | –0.56 % | 131.21 | 4.3 | 17.23 | DoubleVerify merger update pending regulatory clearance. |
| TENB | +4.34 % | 41.86 | 4.3 | 674.78 | High valuation; earnings multiple elevated. |
| ITGR | 0 % | 126.60 | 4.3 | 34.40 | Shareholder approval of merger with Armstrong Parent, Inc. |
| EWTX | –0.25 % | 40.02 | 4.3 | – | Minor price decline; market cap unchanged. |
Company Overview
Veracyte, Inc. is a biotechnology firm headquartered in South San Francisco, California, that develops molecular diagnostic tests for oncology. The company’s products enhance the accuracy of cytology samples through molecular cytology techniques. Veracyte’s services are sold to healthcare providers and molecular diagnostic companies in the United States. The company is listed on the Nasdaq stock exchange; its initial public offering occurred on 30 Oct 2013. The corporate website is www.veracyte.com .
